Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03185767
What this trial is testing

Long Non Coding RNA in Complications of Systemic Lupus

Who this might be right for
Complication in Systemic Lupus Erythematosus
Cairo University 100
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT04376827
What this trial is testing

Guselkumab in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 33
Post-approval studies (Phase 4)UnknownNCT04145687
What this trial is testing

Metformin In Prevention of Lupus Nephritis

Who this might be right for
Lupus Nephritis
RenJi Hospital 30
Early research (Phase 1)Ended earlyNCT01369628
What this trial is testing

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Who this might be right for
Lupus Nephritis
EMD Serono 1
Not applicableUnknownNCT04218890
What this trial is testing

TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 100
Not applicableStudy completedNCT04522505
What this trial is testing

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 6
Testing effectiveness (Phase 2)WithdrawnNCT00390091
What this trial is testing

Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
La Jolla Pharmaceutical Company
Large-scale testing (Phase 3)Study completedNCT02630628
What this trial is testing

Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 130
Testing effectiveness (Phase 2)Ended earlyNCT05540665
What this trial is testing

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Amgen 19
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Testing effectiveness (Phase 2)UnknownNCT04835883
What this trial is testing

Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Hanyang University Seoul Hospital 10
Large-scale testing (Phase 3)Ended earlyNCT01765842
What this trial is testing

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy

Who this might be right for
Lupus Nephritis
Fundación Pública Andaluza Progreso y Salud 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT07044115
What this trial is testing

Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis

Who this might be right for
Lupus Nephritis
Beijing Mabworks Biotech Co., Ltd. 41
Not applicableNot Yet RecruitingNCT07837544
What this trial is testing

Diastolic Dysfunction and Inflammatory Biomarkers in Lupus Nephritis

Who this might be right for
Lupus NephritisDiastolic DysfunctionSystemic Lupus Erythematosus+1 more
Assiut University 90
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Not applicableNot Yet RecruitingNCT07130448
What this trial is testing

The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)SLE - Systemic Lupus ErythematosusBiomarkers
Assiut University 120
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Large-scale testing (Phase 3)Looking for participantsNCT06904729
What this trial is testing

Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children

Who this might be right for
Lupus Nephritis
Guangzhou Women and Children's Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Next Page